# Cellectar Biosciences, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:eb1e0a58-f201-45a2-8321-59e5e35bab43 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/cellectar-biosciences-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 18 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-24T04:47:12.428715+00:00 | | Last reviewed | 2026-10-24T04:47:12.428715+00:00 | ## Identity - Legal name: Cellectar Biosciences, Inc. - Display name: Cellectar Biosciences, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-25T00:20:53.600978+00:00 | | Completeness | 0.409 | | Record Quality | 0.837 | | Directors | 6 | | Committees | 4 | | Governance events | 13 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Asher Chanan-Khan, M.B.B.S., M.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:leadership_role:5 - Douglas J. Swirsky: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:leadership_role:6 - Frederick W. Driscoll: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Audit (chair); Audit · Chair; Compensation (member); Compensation (member). claim_id=alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:leadership_role:7 - James V. Caruso: Director. Status: current. Independent: false. Since: 2015-01-01. claim_id=alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:leadership_role:8 - John Neis: Director. Status: current. Independent: true. Since: 2008-01-01. Committees: Compensation (chair); Compensation · Chair (member). claim_id=alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:leadership_role:9 - Stefan D. Loren, Ph.D.: Director. Status: current. Independent: true. Since: 2015-01-01. claim_id=alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:leadership_role:10 ## Committees - Audit (audit). Chair: Frederick W. Driscoll. Members: Frederick W. Driscoll (chair, current). committee_id=alpha:committee:cellectar-biosciences-inc:audit - Audit · Chair; Compensation (audit). Chair: NOT_PUBLISHED. Members: Frederick W. Driscoll (member, current). committee_id=alpha:committee:cellectar-biosciences-inc:audit-chair-compensation - Compensation (compensation). Chair: John Neis. Members: John Neis (chair, current); Douglas J. Swirsky (member, current); Frederick W. Driscoll (member, current). committee_id=alpha:committee:cellectar-biosciences-inc:compensation - Compensation · Chair (compensation). Chair: NOT_PUBLISHED. Members: John Neis (member, current). committee_id=alpha:committee:cellectar-biosciences-inc:compensation-chair ## Executive leadership - Chad J. Kolean: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:leadership_role:11 - James V. Caruso: President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:leadership_role:12 ## Governance events - CFO_CHANGED: Chad J. Kolean executive of Cellectar Biosciences, Inc., effective 2026-03-04. Effective: 2026-03-04. Detected: 2026-10-24T04:47:12.428715+00:00. event_id=alpha:event:transition:pxfzp2qsp1nk - CEO_CHANGED: James V. Caruso executive of Cellectar Biosciences, Inc., effective 2026-03-04. Effective: 2026-03-04. Detected: 2026-10-24T04:47:12.428715+00:00. event_id=alpha:event:transition:19oszkbwquxor - DIRECTOR_APPOINTED: Asher Chanan-Khan, M.B.B.S., M.D. seat on Cellectar Biosciences, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-24T04:47:12.428715+00:00. event_id=alpha:event:transition:4rvq2uol1spm - DIRECTOR_APPOINTED: Douglas J. Swirsky seat on Cellectar Biosciences, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:47:12.428715+00:00. event_id=alpha:event:transition:a2iy6yk6nekg - DIRECTOR_APPOINTED: Frederick W. Driscoll seat on Cellectar Biosciences, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:47:12.428715+00:00. event_id=alpha:event:transition:1hrqbaj19vvvup - COMMITTEE_CREATED: Audit · Chair; Compensation committee of Cellectar Biosciences, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:47:12.428715+00:00. event_id=alpha:event:transition:50wbt122uk9p - COMMITTEE_MEMBER_ADDED: Frederick W. Driscoll member of Audit · Chair; Compensation, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:47:12.428715+00:00. event_id=alpha:event:transition:1me7yvo1blx2d8 - COMMITTEE_MEMBER_ADDED: Douglas J. Swirsky member of Compensation, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:47:12.428715+00:00. event_id=alpha:event:transition:urb1zq14q6ofk - DIRECTOR_APPOINTED: James V. Caruso seat on Cellectar Biosciences, Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-24T04:47:12.428715+00:00. event_id=alpha:event:transition:im36n01plmv54 - DIRECTOR_APPOINTED: Stefan D. Loren, Ph.D. seat on Cellectar Biosciences, Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-24T04:47:12.428715+00:00. event_id=alpha:event:transition:17lkhuxwy1ktl - DIRECTOR_APPOINTED: John Neis seat on Cellectar Biosciences, Inc., effective 2008-01-01. Effective: 2008-01-01. Detected: 2026-10-24T04:47:12.428715+00:00. event_id=alpha:event:transition:1jwl0cfhu0s61 - COMMITTEE_CREATED: Compensation · Chair committee of Cellectar Biosciences, Inc., effective 2008-01-01. Effective: 2008-01-01. Detected: 2026-10-24T04:47:12.428715+00:00. event_id=alpha:event:transition:1inx04z1qt8c35 - COMMITTEE_MEMBER_ADDED: John Neis member of Compensation · Chair, effective 2008-01-01. Effective: 2008-01-01. Detected: 2026-10-24T04:47:12.428715+00:00. event_id=alpha:event:transition:1gh9wjsqrtzyk ## Scoped resources - `alpha://company/cellectar-biosciences-inc` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record - `alpha://company/cellectar-biosciences-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=identity - `alpha://company/cellectar-biosciences-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=corporate-structure - `alpha://company/cellectar-biosciences-inc/board` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=board - `alpha://company/cellectar-biosciences-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=committees - `alpha://company/cellectar-biosciences-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=leadership - `alpha://company/cellectar-biosciences-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=ownership - `alpha://company/cellectar-biosciences-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=financials - `alpha://company/cellectar-biosciences-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=capital-structure - `alpha://company/cellectar-biosciences-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=compensation - `alpha://company/cellectar-biosciences-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=governance - `alpha://company/cellectar-biosciences-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=shareholder-governance - `alpha://company/cellectar-biosciences-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=audit - `alpha://company/cellectar-biosciences-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=legal - `alpha://company/cellectar-biosciences-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=risk - `alpha://company/cellectar-biosciences-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=cyber - `alpha://company/cellectar-biosciences-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=ai-governance - `alpha://company/cellectar-biosciences-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=agents - `alpha://company/cellectar-biosciences-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=ecosystem - `alpha://company/cellectar-biosciences-inc/events` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=events - `alpha://company/cellectar-biosciences-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=relationships - `alpha://company/cellectar-biosciences-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=assessments - `alpha://company/cellectar-biosciences-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:frederick-w-driscoll","name":"Frederick W. Driscoll"},"source_id":"board_seats"}` - Claim alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:john-neis","name":"John Neis"},"source_id":"board_seats"}` - Claim alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:douglas-j-swirsky","name":"Douglas J. Swirsky"},"source_id":"board_seats"}` - Claim alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:frederick-w-driscoll","name":"Frederick W. Driscoll"},"source_id":"board_seats"}` ## Leadership - Asher Chanan-Khan, M.B.B.S., M.D.: Director. Claim: alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:leadership_role:5. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d6c2f1978e28cece88f124792542da5321c07d535f352da19b217a1258016241. - Douglas J. Swirsky: Director, Compensation. Claim: alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:leadership_role:6. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d6c2f1978e28cece88f124792542da5321c07d535f352da19b217a1258016241. - Frederick W. Driscoll: Director, Audit · Chair; Compensation. Claim: alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:leadership_role:7. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d6c2f1978e28cece88f124792542da5321c07d535f352da19b217a1258016241. - James V. Caruso: Director. Claim: alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:leadership_role:8. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d6c2f1978e28cece88f124792542da5321c07d535f352da19b217a1258016241. - John Neis: Director, Compensation · Chair. Claim: alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:leadership_role:9. Valid from: 2008-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d6c2f1978e28cece88f124792542da5321c07d535f352da19b217a1258016241. - Stefan D. Loren, Ph.D.: Director. Claim: alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:leadership_role:10. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d6c2f1978e28cece88f124792542da5321c07d535f352da19b217a1258016241. - Chad J. Kolean: Chief Financial Officer. Claim: alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:leadership_role:11. Valid from: 2026-03-04. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2fed54e3dbfe29cd2ab23ee17cdcce9b7d1087472863c0caad6a38cc25bcea46. - James V. Caruso: President and Chief Executive Officer. Claim: alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:leadership_role:12. Valid from: 2026-03-04. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:48e59bf474fe7c7eee59d2d80256bc0902b3d2d248067bd62010d2b7dc4f6a23. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Frederick W. Driscoll; Members Frederick W. Driscoll (Chair). Claim: alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:committee_record:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0c5cbca7bc6c35dae3db776ca0d02ddfec5b78fed10d5accb7eb9a342cce6d99. - Compensation: Chair John Neis; Members John Neis (Chair); Douglas J. Swirsky; Frederick W. Driscoll. Claim: alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:committee_record:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0c5cbca7bc6c35dae3db776ca0d02ddfec5b78fed10d5accb7eb9a342cce6d99. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Cellectar Biosciences, Inc.. Claim: alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:02a953d9af34a6967a80fe7b6e7c946ecc937df5829c9d9511733020f6a0b370. ## Entity Status - Public listing published. Claim: alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:02a953d9af34a6967a80fe7b6e7c946ecc937df5829c9d9511733020f6a0b370. ## Published Fact - US. Claim: alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:02a953d9af34a6967a80fe7b6e7c946ecc937df5829c9d9511733020f6a0b370. ## Committee Appointment - Frederick W. Driscoll: chair, Audit. Claim: alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0c5cbca7bc6c35dae3db776ca0d02ddfec5b78fed10d5accb7eb9a342cce6d99. - John Neis: chair, Compensation. Claim: alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0c5cbca7bc6c35dae3db776ca0d02ddfec5b78fed10d5accb7eb9a342cce6d99. - Douglas J. Swirsky: member, Compensation. Claim: alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0c5cbca7bc6c35dae3db776ca0d02ddfec5b78fed10d5accb7eb9a342cce6d99. - Frederick W. Driscoll: member, Compensation. Claim: alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0c5cbca7bc6c35dae3db776ca0d02ddfec5b78fed10d5accb7eb9a342cce6d99. ## Security Listing - CLRB (NASDAQ). Claim: alpha:claim:company:eb1e0a58-f201-45a2-8321-59e5e35bab43:security_listing:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:02a953d9af34a6967a80fe7b6e7c946ecc937df5829c9d9511733020f6a0b370. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:02a953d9af34a6967a80fe7b6e7c946ecc937df5829c9d9511733020f6a0b370: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/cellectar-biosciences-inc). - alpha:projection-evidence:document:d6c2f1978e28cece88f124792542da5321c07d535f352da19b217a1258016241: [Cellectar Biosciences, Inc. DEF 14A 2025-04-28](https://www.sec.gov/Archives/edgar/data/1279704/000110465925040241/tm2512660-4_def14a.htm). - alpha:projection-evidence:document:2fed54e3dbfe29cd2ab23ee17cdcce9b7d1087472863c0caad6a38cc25bcea46: [CLRB 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1279704/000110465926023167/clrb-20251231x10k.htm). - alpha:projection-evidence:document:48e59bf474fe7c7eee59d2d80256bc0902b3d2d248067bd62010d2b7dc4f6a23: [CLRB 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1279704/000110465926023167/clrb-20251231x10k.htm). - alpha:projection-evidence:0c5cbca7bc6c35dae3db776ca0d02ddfec5b78fed10d5accb7eb9a342cce6d99: [Audit](https://www.sec.gov/Archives/edgar/data/1279704/000110465925040241/tm2512660-4_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/cellectar-biosciences-inc) - [Public Markdown](https://registry.alpha.ac/companies/cellectar-biosciences-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/cellectar-biosciences-inc?format=jsonld) - MCP resource: `alpha://companies/cellectar-biosciences-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-25T00:20:53.344203+00:00; recorded 2026-10-25T00:20:53.344203+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.